NCT06139211 2024-12-20
A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Phase 1/2 Recruiting
Shanghai Junshi Bioscience Co., Ltd.
Qilu Pharmaceutical Co., Ltd.
Beijing Biostar Pharmaceuticals Co., Ltd.
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.